Verified Nov 2026
Batteries & E-Mobility
·
Burlington, Massachusetts
·
Since 2011
Azenta Life Sciences is a publicly traded biotechnology company headquartered in Burlington, Massachusetts, founded in 2011 and listed under the ticker AZTA. It employs between 1,000 and 5,000 people and reports revenue in the range of $593.8 million. The company provides sample management and genomic services to pharmaceutical, biotech, academic, and healthcare organizations, including automated ultra-cold storage and custom DNA sequencing under the GENEWIZ brand. In March 2026 it completed its acquisition of UK Biocentre Limited to expand its biorepository capabilities.
Azenta Life Sciences at a glance
Revenue
593.8M
Employees
1,000-5,000
Founded
2011
Headquarters
Burlington, Massachusetts
Ownership
Publicly traded (NASDAQ: AZTA)
Certifications
ISO 13485 · ISO 9001
Import activity
279
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
279
Named foreign suppliers
26
Top origins
South Korea · United Kingdom · Taiwan · China
Shared foreign counterparties do not establish that these companies buy from Azenta Life Sciences.
What this tells a buyer
Azenta announced in March 2026 that it completed the acquisition of UK Biocentre Limited, expanding its biorepository capabilities, and in October 2026 it announced strategic investments to advance its GENEWIZ gene synthesis capabilities.
The company lists ISO 13485 and ISO 9001 certifications and offers products and services spanning automated sample storage, outsourced repository services, cold-chain logistics, and genomic services.
Azenta is a publicly listed company that serves the life sciences sector, with a reported workforce of 1,000 to 5,000 employees and an announced partnership with Frontier Space in February 2026 on space-based life sciences research.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & strong
15 years in operation (founded 2011).
Publicly listed; no distress event on record.
Holds ISO 13485, ISO 9001 certification(s) per public sources.
Overview
Azenta Life Sciences is a publicly traded biotechnology company headquartered in Burlington, Massachusetts, founded in 2011 and listed under the ticker AZTA. It employs between 1,000 and 5,000 people and reports revenue in the range of $593.8 million. The company provides sample management and genomic services to pharmaceutical, biotech, academic, and healthcare organizations, including automated ultra-cold storage and custom DNA sequencing under the GENEWIZ brand. In March 2026 it completed its acquisition of UK Biocentre Limited to expand its biorepository capabilities.
At a glance
Attribute | Detail |
|---|---|
Founded | 2011 |
Headquarters | Burlington, Massachusetts |
Employees | 1,000-5,000 |
Revenue | 593.8M |
Ownership | Publicly traded (NASDAQ: AZTA) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 · ISO 9001 |
What Azenta Life Sciences makes
The company lists ISO 13485 and ISO 9001 certifications and offers products and services spanning automated sample storage, outsourced repository services, cold-chain logistics, and genomic services.
Products and capabilities described on the company's own site include Injection Molding, Seal, Adhesive, Welding, Assembly, Plastic (source: azenta.com).
Certifications
Azenta Life Sciences is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — azenta.com
ISO 9001 — azenta.com
Trade and customs footprint
Azenta announced in March 2026 that it completed the acquisition of UK Biocentre Limited, expanding its biorepository capabilities, and in October 2026 it announced strategic investments to advance its GENEWIZ gene synthesis capabilities. US customs bill-of-lading records list 279 inbound shipments across 26 foreign suppliers, with top origins including South Korea · United Kingdom · Taiwan · China.
Latest developments
2026-10-30 — Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities - Oct 30, 2026 (azenta.com)
2026-10-30 — Azenta, Inc. Form 8-K filed October 30, 2026 (sec.gov)
2026-03-04 — Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities - Mar 4, 2026 (azenta.com)
2026-02-09 — Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure - Feb 9, 2026 (azenta.com)
2025-11-04 — Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer - Nov 4, 2025 (azenta.com)
2025-07-31 — Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology - Jul 31, 2025 (azenta.com)
Facilities
Azenta Life Sciences is headquartered in Burlington, Massachusetts. Public sources also reference these locations:
Milton Keynes, England — azenta.com
Company details
Azenta is a publicly listed company that serves the life sciences sector, with a reported workforce of 1,000 to 5,000 employees and an announced partnership with Frontier Space in February 2026 on space-based life sciences research. Azenta Life Sciences was founded in 2011, has an estimated 1,000-5,000 employees, and is headquartered in Burlington, Massachusetts. On the LightSource stability read it is rated "Established & strong": 15 years in operation (founded 2011). Publicly listed; no distress event on record. Holds ISO 13485, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Azenta Life Sciences make?
Azenta Life Sciences is a publicly traded biotechnology company headquartered in Burlington, Massachusetts, founded in 2011 and listed under the ticker AZTA. It employs between 1,000 and 5,000 people and reports revenue in the range of $593.8 million. The company provides sample management and genomic services to pharmaceutical, biotech, academic, and healthcare organizations, including automated ultra-cold storage and custom DNA sequencing under the GENEWIZ brand. In March 2026 it completed its acquisition of UK Biocentre Limited to expand its biorepository capabilities.
Where is Azenta Life Sciences headquartered?
Azenta Life Sciences is headquartered in Burlington, Massachusetts.
When was Azenta Life Sciences founded?
Azenta Life Sciences was founded in 2011.
How big is Azenta Life Sciences?
Azenta Life Sciences has an estimated 1,000-5,000 employees, with revenue in the 593.8M range.
Is Azenta Life Sciences publicly traded?
Publicly traded (NASDAQ: AZTA). Public financial figures are drawn from its filings.
What certifications does Azenta Life Sciences hold?
Azenta Life Sciences lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.